StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Lowered to $382 at SVB Leerink
November 9, 2020 4:39 AM
SVB Leerink analyst Marc H. Goodman lowered the price target on Biogen (NASDAQ:
BIIB
) to $382.00 (from $402.00) while maintaining a Outperform rating.
Categories
Analyst PT Change
Next Articles
Cowen Downgrades Biogen (BIIB) to Market Perform
November 9, 2020 6:18 AM